Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
While we agree that “what got us here (an affordable generics powerhouse) will ...
Reportedly, 400+ delegates and 50 speakers were part of the summit The post IPA...
When patient safety is on the line, you need answers in minutes, not days. As s...
The acquisition will expand the company’s speciality pharmaceutical platform int...
FOP is an ultra-rare condition, impacting fewer than 1,000 people worldwide. The...
Inspection conducted in November 2025; Establishment Inspection Report issued b...
Transaction marks entry into global naturals market and sets up manufacturing a...
Company scores 91 out of 100; included in Sustainability Yearbook 2026 for thir...
Product bioequivalent to Hospira reference drug; IQVIA reports $66.8 million an...
Findings released ahead of Shingles Action Week show low awareness and limited ...
The acquisition includes five sites specialising in various in vitro drug discov...
Vivtex will license to Novo Nordisk select oral drug-delivery technologies and i...
Initiative positions obesity as a chronic disease and highlights role of doctor...
Darolutamide plus ADT cleared for mHSPC, supported by ARANOTE Phase III data wi...
Company secures final approval for ANDA across four strengths; cumulative USFDA...
Brecht Vanneste to take charge of MSD India operations from 1 March 2026, based...